{"id":754000,"date":"2026-06-22T17:25:38","date_gmt":"2026-06-22T17:25:38","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/754000\/"},"modified":"2026-06-22T17:25:38","modified_gmt":"2026-06-22T17:25:38","slug":"getting-the-dosage-right-1-2m-awarded-for-diagnostic-tech-that-could-transform-mental-health-care","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/754000\/","title":{"rendered":"Getting the dosage right: $1.2M awarded for diagnostic tech that could transform mental health care"},"content":{"rendered":"<p>Researchers at McMaster University are\u00a0developing a pair of rapid diagnostic tools that could slash wait-times\u00a0for critical drug-monitoring results,\u00a0allowing clinicians to\u00a0personalize\u00a0treatments for mental health conditions in real-time.\u00a0\u00a0\u00a0<\/p>\n<p>With psychotropic\u00a0medications,\u00a0which are\u00a0prescribed for many mental health disorders,\u00a0the line\u00a0between therapy and toxicity is vanishingly thin. Too small a dose, and the medication will have no effect. Too much, and the same drug can trigger dangerous side effects.\u00a0<\/p>\n<p>The challenge\u00a0for prescribers\u00a0is that\u00a0there is no\u00a0one-size-fits-all\u00a0solution for these drugs.\u00a0Age, genetics, metabolism, diet, and other medications can\u00a0all\u00a0change\u00a0where the line between therapy and toxicity sits, making each\u00a0individual\u00a0patient a unique case.\u00a0\u00a0<\/p>\n<p>In recent years,\u00a0clinicians have\u00a0eliminated much of the guesswork\u00a0from\u00a0dosing\u00a0through\u00a0an advanced\u00a0laboratory technique\u00a0called\u00a0therapeutic drug monitoring (TDM). TDM allows for clinicians to\u00a0more precisely tailor a drug\u2019s dosage\u00a0to a specific patient\u2019s needs\u00a0by\u00a0monitoring\u00a0exactly how much\u00a0of\u00a0the\u00a0drug is circulating in\u00a0their\u00a0bloodstream, and\u00a0adjusting dosage accordingly.\u00a0\u00a0<\/p>\n<p>But TDM takes time \u2014 often up to 15 days for results to arrive\u00a0from\u00a0specialized\u00a0laboratories.\u00a0\u00a0<\/p>\n<p>\u201cFor patients, these delays can feel like an eternity,\u201d says Leyla Soleymani, a professor of engineering physics at McMaster University. \u201cEnduring weeks of ineffective treatment or serious side-effects is not only\u00a0difficult for\u00a0patients, but it can quickly\u00a0shake\u00a0their trust in health care\u00a0and leave them even more vulnerable to\u00a0the impacts of\u00a0mental health\u00a0disorders.\u201d\u00a0\u00a0<\/p>\n<p>That\u2019s\u00a0why\u00a0Soleymani\u2019s group is aiming to shrink TDM\u2019s 15-day wait time\u00a0down\u00a0to just 10\u00a0short\u00a0minutes.\u00a0\u00a0<\/p>\n<p>With $1.2 million in new funding from the Natural Sciences and Engineering Research Council of Canada (NSERC), her team is developing the\u00a0world\u2019s\u00a0first rapid,\u00a0point-of-care diagnostics for TDM\u00a0of psychotropic drugs: a\u00a0handheld\u00a0finger-prick blood test and a wearable device\u00a0that uses microneedle tech\u00a0for real-time drug monitoring.\u00a0<\/p>\n<p>Both devices are being designed to deliver\u00a0lab-accurate results in the span of a single doctor\u2019s appointment.\u00a0<\/p>\n<p>Karin Neufeld, chair of the Department of Psychiatry and Behavioural Neurosciences at McMaster and a collaborator on the project, says\u00a0that\u00a0the rising burden of mental health disorders is creating an urgent need for faster, more accessible approaches to\u00a0TDM.\u00a0\u00a0<\/p>\n<p>\u201cMental health disorders are very prevalent and there is a significant need for timely therapeutic\u00a0drug\u00a0monitoring strategies,\u201d says Neufeld, who\u00a0is also a psychiatrist at St. Joseph\u2019s Healthcare Hamilton\u2019s community\u00a0psychiatry\u00a0clinic. \u201cThese new technologies\u00a0have the potential to transform drug monitoring in mental health, expand access in remote settings, and enable timely, personalized care with meaningful impact for patients and healthcare systems.\u201d\u00a0\u00a0<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-32929\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/06\/IMG_0912_Blake-Dillon-scaled.jpg\" alt=\"A close-up of four small, circular patches displayed on a petri dish. \" width=\"2560\" height=\"1707\"  \/>The new wearable tech uses pain-free microneedle patches to detect drug volumes in the blood and interstitial fluid.<\/p>\n<p>Both the finger-prick test and the wearable will be powered by new aptamers \u2014 tiny strands of DNA that are engineered to recognize specific molecules. Researchers will integrate these aptamers into the devices\u2019 electronic chips, which generate electrical signals when they detect traces of specific drugs within the bloodstream\u00a0or the skin interstitial fluid. The data is then beamed to a nearby smartphone for almost instantaneous results.\u00a0\u00a0\u00a0<\/p>\n<p>Soleymani, who\u00a0leads engineering innovation\u00a0for\u00a0NexusHealth\u00a0at McMaster,\u00a0notes that\u00a0the development of these\u00a0new diagnostics\u00a0has been informed by\u00a0personal\u00a0discussions with patients, their families, and their care providers.\u00a0\u00a0\u00a0<\/p>\n<p>\u201cInitially, we intended to develop a minute-by-minute, at-home monitoring device, but we heard directly from patients\u00a0and clinicians\u00a0that\u00a0it didn\u2019t resonate with them,\u201d\u00a0says\u00a0Soleymani, who is also an associate member of McMaster\u2019s\u00a0Department of Biochemistry and Biomedical Sciences\u00a0and School of Biomedical Engineering. \u201cWe heard about their wants and needs, and those of their care providers, and we changed course completely.\u201d\u00a0\u00a0<\/p>\n<p>These\u00a0critical co-design\u00a0consultations,\u00a0brokered by\u00a0the Research Institute at St. Joseph\u2019s Health System,\u00a0provided the research team with fundamental insights about\u00a0product design.\u00a0For example,\u00a0determining\u00a0where\u00a0patients\u00a0would\u00a0use the devices changed\u00a0their\u00a0architecture, and\u00a0understanding\u00a0how\u00a0frequently\u00a0the devices\u00a0would be\u00a0used changed\u00a0the chemistry involved.\u00a0<\/p>\n<p>\u201cPatient voices and lived experience have helped shape this work from its earliest stages,\u201d says Sarah Howe, chief operating officer at\u00a0the Research Institute at?St. Joseph\u2019s Health System.\u00a0\u201cBuilding new technologies hand-in-hand with the patients, families,\u00a0and clinicians who will use them is the definition of compassionate innovation.\u201d\u00a0<\/p>\n<p>Soleymani\u2019s team is\u00a0now\u00a0working closely on the development of these new diagnostics with\u00a0Mahla\u00a0Poudineh\u00a0and\u00a0Juewen\u00a0Liu, both researchers at the University of Waterloo.\u00a0Poudineh,\u00a0an expert in\u00a0wearable\u00a0biosensing technologies for therapeutic and diagnostic applications, and Liu,\u00a0a leader in DNA aptamer research, are both longtime collaborators of the McMaster team.\u00a0\u00a0<\/p>\n<p>\u201cThis\u00a0project\u00a0comes\u00a0after\u00a0years of\u00a0collaborative\u00a0research\u00a0between our groups,\u201d says\u00a0Poudineh, an associate professor of electrical and\u00a0computer\u00a0engineering. \u201cBy combining the McMaster team\u2019s expertise in DNA\u00a0sensors\u00a0with\u00a0Waterloo\u2019s\u00a0expertise\u00a0in microneedle technologies and aptamers, we\u2019re\u00a0now working toward the development of\u00a0new\u00a0wearable diagnostics that could make\u00a0TDM\u00a0faster\u00a0and more accessible for patients.\u201d\u00a0<\/p>\n<p>\u201cOur history of collaboration on aptamer-based biosensors positions\u00a0this project for success,\u201d adds Liu, a professor of chemistry. \u201cAlready, we have worked together on similar diagnostics for lactate monitoring, giving us a strong foundation\u00a0to build from.\u201d\u00a0<\/p>\n<p>As the new devices\u00a0take shape, the research team will collaborate with experts at\u00a0LifeLabs\u00a0to bring\u00a0this innovative technology into the hands of\u00a0the\u00a0healthcare teams and patients that need it most. That partnership is critical, Soleymani says, because\u00a0LifeLabs\u00a0has the infrastructure and\u00a0expertise\u00a0to support both\u00a0the\u00a0de-risking\u00a0and validation\u00a0needed to bring\u00a0the\u00a0new diagnostics\u00a0into clinical practice.\u00a0<\/p>\n<p>Catherine Ross, vice-president of medical and quality affairs at LifeLabs, says the development of rapid, painless, and practical devices like these align well with LifeLabs\u2019 commitment to delivering patient-centred solutions that elevate quality of care across the country.\u00a0\u00a0<\/p>\n<p>\u201cWe have a responsibility to continually raise the bar for patient care,\u201d says Ross. \u201cThat means making laboratory services\u00a0that empower healthier Canadians while\u00a0maintaining the highest standards of quality and clinical excellence.\u201d\u00a0\u00a0<\/p>\n<p>Soleymani\u00a0anticipates\u00a0that the\u00a0new technologies\u00a0will\u00a0be\u00a0prototyped and ready for clinical validation\u00a0within four years.<\/p>\n","protected":false},"excerpt":{"rendered":"Researchers at McMaster University are\u00a0developing a pair of rapid diagnostic tools that could slash wait-times\u00a0for critical drug-monitoring results,\u00a0allowing&hellip;\n","protected":false},"author":2,"featured_media":754001,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[49,48,84],"class_list":["post-754000","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-ca","tag-canada","tag-health"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/754000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=754000"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/754000\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/754001"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=754000"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=754000"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=754000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}